Virtual Access Only | 5.00 CE/CME Credits & MOC Points
The Best of Breast Conference will take place on February 22, 2025. This innovative and state of the art program is set in a multidisciplinary tumor board environment featuring some of the world's leading breast cancer experts to discuss cases beginning with high-risk characteristics, adjuvant and metastatic treatment advances, interdisciplinary care, and survivorship and recurrence—all while incorporating data from the major oncologic annual meetings.
Conference Agenda
Saturday, February 22, 2025
8:00 AM
Welcome and Exhibits
8:30 AM
Program Chair Opening Remarks
8:35 AMCDK4/6 Inhibitors in HR+/HER2- Breast Cancer: Latest Advances
Early Stage ER+ Case Moderator: Reshma Mahtani, DO | Miami Cancer Institute Joseph Panoff, MD | Miami Cancer Institute Taiwo Adesoye, MD, MPH | MD Anderson Cancer Center
Naomi Dempsey, MD | Baptist Health South Florida
9:35 AM
Break and Exhibits
9:50 AM
Early Stage Triple Negative Case Moderator: Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center
Rita Nanda, MD | The University of Chicago Medical Center Sunil Badve, MD, FRCPath | Emory Winship Cancer Institute Taiwo Adesoye, MD, MPH | MD Anderson Cancer Center
Emily Gallagher, MD, PhD | Mount Sinai
10:50 AM
Break and Exhibits
11:05 AM
NON-CME/CE SESSION - Pfizer - Treatment Considerations for Specific Populations With HR+/HER2- mBC: Endocrine Sensitivity and ≥65 Years
Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center
11:50 AM
Break and Exhibits
12:05 PM
Metastatic ER+ Case Moderator: Reshma Mahtani, DO | Miami Cancer Institute Ruta Rao, MD | RUSH University
Ashwin Mehta, MD | Memorial Healthcare System
Sunil Badve, MD, FRCPath | Emory Winship Cancer Institute
1:05 PM
Her2 Positive Case Moderator: Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center Joseph Panoff, MD | Miami Cancer Institute Sunil Badve, MD, FRCPath | Emory Winship Cancer Institute
Mark Pegram, MD | Stanford University School of Medicine
2:05 PM
Break and Exhibits
2:20 PM
Non-CME Session provided by Gilead
3:05 PM
Break and Exhibits
3:20 PM
Integrative Medicine
Ashwin Mehta, MD | Memorial Healthcare System
3:50 PM
Dawn Oncology: A Novel Telehealth Solution for Whole Person Survivorship Care
Neil Iyengar, MD | Memorial Sloan Kettering Cancer Center
Gil Kazimirov | Dawn Oncology
4:05 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various breast cancers.
Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with breast cancer.
Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with breast cancer.
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 5.00 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 5.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 5.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources